Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy

Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy

In patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF), three months of optimal therapy are recommended before considering a primary preventive implantable cardioverter-defibrillator (ICD). It is unclear which patients benefit from a prolonged waiting period under prot...

Full description

Bibliographic Details
Main Authors:	Johanna Mueller-Leisse, Johanna Brunn, Christos Zormpas, Stephan Hohmann, Henrike Aenne Katrin Hillmann, Jörg Eiringhaus, Johann Bauersachs, Christian Veltmann, David Duncker
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Sensors
Subjects:	HFrEF heart failure WCD (wearable cardioverter-defibrillator) ICD (implantable cardioverter-defibrillator) LVEF (left ventricular ejection fraction) SCD (sudden cardiac death)
Online Access:	https://www.mdpi.com/1424-8220/22/5/2037

Similar Items

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
by: Johanna Mueller‐Leisse, et al.
Published: (2021-12-01)

Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
by: Henrike Aenne Katrin Hillmann, et al.
Published: (2021-11-01)

Does Patient Compliance Influence Wearable Cardioverter Defibrillator Effectiveness? A Single-Center Experience
by: Luca Fazzini, et al.
Published: (2023-07-01)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)

S-ICD Implantation "Tips and Tricks"
by: Szymon Budrejko, et al.
Published: (2023-07-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
by: Daniel B. Kramer, et al.
Published: (2015-05-01)

Perioperative Sensor and Algorithm Programming in Patients with Implanted ICDs and Pacemakers for Cardiac Resynchronization Therapy
by: Alexander Niedermeier, et al.
Published: (2021-12-01)

Periprocedural decrease in tumor necrosis factor alpha is a risk factor for atrial fibrillation recurrence after ablation
by: Ewa Szczerba, et al.
Published: (2022-12-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
by: Christos Zormpas, et al.
Published: (2022-06-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
by: Szymon Budrejko, et al.
Published: (2023-12-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Extraction of physiological parameters to screen potential implantable cardiac defibrillator (ICD) receiver /
by: Tan, Wei Kiat, 1989-, author, et al.
Published: (2013)

Extraction of physiological parameters to screen potential implantable cardiac defibrillator (ICD) receiver /
by: Tan, Wei Kiat, 1989-, author, et al.
Published: (2013)

Implantable Cardiac Defibrillator (ICD) receiver screening tool /
by: Norzahirah Mohd. Rodi, 1993-, author 637545, et al.
Published: (2015)

Implantable Cardiac Defibrillator (ICD) receiver screening tool [electronic resource] /
by: Norzahirah Mohd. Rodi, 1993- author 637545
Published: (2015)

Implantable cardioverter-defibrillators step by step : an illustrated guide /
by: 439461 Stroobandt, Roland X., et al.
Published: (2009)

Usefulness of the MAGGIC Score in Predicting the Competing Risk of Non-Sudden Death in Heart Failure Patients Receiving an Implantable Cardioverter-Defibrillator: A Sub-Analysis of the OBSERVO-ICD Registry
by: Marco Canepa, et al.
Published: (2021-12-01)

ICD Outcome in Pediatric Cardiomyopathies
by: Massimo Stefano Silvetti, et al.
Published: (2022-01-01)

Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series
by: Viveka Kumar, et al.
Published: (2022-04-01)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)

Systematic Review on S-ICD Lead Extraction
by: Riccardo Vio, et al.
Published: (2023-05-01)

An inappropriately–appropriate ICD therapy: What is the mechanism and what interventions can be done?
by: Athanasios Saplaouras, et al.
Published: (2023-10-01)

Implantable Cardioverter Defibrillator Stored ECGs [electronic resource]: Clinical Management and Case Reports/
by: 410467 Jordaens, Luc J., et al.
Published: (2007)

Cardiac implantable electronic devices in Bulgaria: results from the electronic registry BG-Pace for 2022
by: V. Traykov, et al.
Published: (2023-12-01)

The patient perspective on remote monitoring of implantable cardiac devices
by: Henrike A. K. Hillmann, et al.
Published: (2023-03-01)

High Defibrillation Threshold: The Science, Signs and Solutions
by: Sony Jacob, et al.
Published: (2010-01-01)

Prevention of Early Sudden Cardiac Death after Myocardial Infarction Using the Wearable Cardioverter Defibrillator—Results from a Real-World Cohort
by: Ursula Rohrer, et al.
Published: (2023-07-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)

Bundle branch block in cardiac arrest survivors without ischemic heart disease
by: Julie Terp Holm, et al.
Published: (2023-04-01)

Diagnostic and management difficulties in congenitally long QT syndrome: a single centre experience
by: Alev Arslan, et al.
Published: (2016-03-01)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
by: Ryan T. Borne, et al.
Published: (2017-03-01)

Implantable cardioverter defibrillator for primary prevention in patients with non-ischemic cardiomyopathy in the era of novel therapeutic agents- meta-analysis
by: Yotam Kolben, et al.
Published: (2023-05-01)

Decision support system to screen potential implantable cardiac defibrillator (ICD) receiver /
by: Hanafi Musa, 1991-, author, et al.
Published: (2014)

Decision support system to screen potential implantable cardiac defibrillator (ICD) receiver [electronic resource] /
by: Hanafi Musa, 1991-, author
Published: (2014)